New combination comprising a beta 2 (beta)₂ adreno receptor agonist and a lenkotriene receptor antagonist

摘要

The invention provides a pharmaceutical composition, pharmaceutical product or kit comprising a first active ingredient which is a beta2 ( beta 2) adrenoreceptor agonist and a second active ingredient which is a leukotriene receptor antagonist, for use in the treatment of inflammatory disorders.